AVNS - Earnings call transcript Q3 2018

Due to licensing restrictions, you must log in to view earnings call transcripts.

Operator

Good morning, and welcome to the Avanos Third Quarter 2018 Earnings Conference Call. [Operator Instructions] Please note this event is being recorded. I would now like to turn the conference over to Dave Crawford, Vice President of Investor Relations. Please go ahead.

Dave Crawford

Good morning, everyone, and thanks for joining us. welcome the to earnings third pleasure call. conference my you Avanos to quarter It’s morning Woody, are Voskuil, this me With Joe President CFO. Senior CEO; and Vice Steve and performance, brief Joe with for our priorities review our outlook progress of and will an on a our begin business. XXXX our financial detail for Steve XXXX. Then additional review performance financial results our our will and offer and on earnings outlook Q&A. call We’ll with finish the the A Investors available Section today’s website, our for presentation on avanos.com. call of is

to today assurance materially comments results. our contain as our the reminder, related and No company, could from performance, statements industry. to a statements. forward-looking can conditions economic differ As in Actual results financial expected forward-looking given those the our future be

results, please today’s and information with SEC. prior release about the see filings statements our more risk forward-looking future factors the press For influence and that could

to measures. has release to Additionally, results we’ll information comparable and be GAAP adjustments on referring The and reconciliations outlook. press financial adjusted these

to I’ll over Now the turn call Joe.

Joe Woody

joining thank Thanks, Dave. Good third for and morning, you, earnings us our everyone, call. quarter on

significant Overall, performance on XX% EPS business we of a growth with During the growth business our a delivered $X.XX, cost to of focus with of transformation the progress investments our base. measuring while continued ahead streamlining on and initiatives this and our adjusted quarter expectation. we solid strategic quarter, topline make and our

XXXX earnings per diluted full share adjusted As $X.XX result, year maintaining of to are a $X.XX. our we guidance

Digestive to Interventional in and our particularly Health, already Game momentum, continued Pain seeing are performance. Ready and We is contributing

in and recently known enhance Chronic by SUPPORT our growth invasive knee non-opioid unmet outpatient to strong highlighted for to share for internationally. momentum for The drive strong over Care Communities nonsurgical continued the Pain market ahead, solutions, procedures as minimally the term. Looking passed continued for and need factors with pain, are long legislation, opportunity portfolio the and continued demand an joint, back Act the Patients the Management expected bipartisan several and

our America. cover Pain, quarter to In North Now franchises another I’d in significant we Interventional like delivered in detail. of growth more double-digit

in to We demand to awareness for invest drive continue patient COOLIEF.

have saw will the Our campaigns Health with grew expectation. ad market are mid-single-digit dynamics results Digestive Care the the coming recent our and in business direct-to-patient successful, these television strong expand line and quarter. over underlying been Chronic healthy. we

we see share overall Care of as in due primarily quarter. the the is to inventory loss and However, expect care. oral some timing softening the in business Chronic This in they distributor to fourth purchases reduce

not for see While items affect do the in our growth we they longer growth to expectations term. business coming expect change these quarter, the

continues previous Our to the industry-wide Acute Pain business headwind, be on impacted by call. discussed

First, lasting have longer shortage suppliers that and we anticipated. is discussed drug previously pre-fillers the drug than industry-wide

headwinds these as than was includes effect fillers longer impacted X For being no allocated quarters regulatory to point due This more a X previous revenue than to points. higher for impact our growth of fill the pumps quarter, customers. by one it pump drugs our

sales vendor seasonality our a to headwinds expect see fourth the contracts fourth transition quality expect will characteristic quarter. to longer on uplift ON-Q efforts the We a process. is progressing particular, limited will new as no the In they of of last we drug greater capacity provide will the our slowly in XXXX. in customers to And and and quarter, gradual is constrain now growth pre-fill partner Second, Leiters supply business. natural ON-Q’s have into XX% The the impact these complete additional with customer audit.

Infusion Pain the to distributors seen consolidation incentive. key in the ON-Q, sales Infusion headwinds year-end look strong as we’ve franchise. of fourth distributors portion in to In IV is recent addition IV the of lower the expected Acute achieve impact to X margin our quarter Historically,

as purchases expect growth for now we fourth organic be we Absent quarter to consolidate enterprise distributors the expected these drug to the However, given consolidation, to headwinds, and joint distributor would’ve shortage the onetime pre-fill work year a inventories. their on X% impact X%.

our rest portfolio our business, growth North year. achieve high the single-digit American still we of for to Excluding expect Acute the Pain

pressures due discussed, just are X%. However, year expectation to enterprise full the Notwithstanding current ON-Q year our we headwinds, of by XXXX Pain growth for sales X% I fundamentals business the solution to to the believe we the Acute the headwinds, our the we that organic growth accounts reducing the opioids are solid, postoperative clinically for patient for seen care. steady reduces and impacted need have for superior not underlying

improve aggressively Acute performance minimizing to to We these and committed in impacts Pain. underlying are the moving

changes us help have and the we focus healing. therapy and on strengthen capitalize pain for orthopedic strategic to management First, our implemented better in demand on Acute this Pain

Second, partnerships we strategic third, our focus build we to deliver to IV continues distributors. deepen sales relationship And look surgeon surgeons orthopedic physician delivered This to results education sustainable as continue and with bolster our customers. positive in with to ON-Q, to force especially procedures. penetration our has ON-Q convert

more forward, Interventional are XXXX time. position support we Looking growth the Cap CPT nerve X investing in which of continue code first in be ablation also shows publication expect ahead ablation. our the study, of acid quarter XXXX. we study, to published completed expect than In nerve Pain, standard and a for over schedule, to clinical the We’ve hyaluronic quarter diverse in health economic we to accelerated completed first during January six that we In business our portfolio for of invest to of cost-effective genicular care, our studies is and the enrollment XXXX. results month

prescribing such the Response Crisis financial encouraged other the for incentives as than rather weeks this medical Among contemplates by also President opioids removal We by are devices new like procedures things, Opioid of two COOLIEF. ago. law bill ON-Q, signed the

to invasive separate educate ON-Q engaging been minimally allow encourage have for them financial procedures and on like them We COOLIEF. with to incentives for like CMS reimbursement devices to and the

Game our Ready integration on and is the Finally, The to contributing of M&A deployment remains capital priority. a of for schedule top growth.

both growth outlook to to across to and our continue opportunities both robust a portfolio. franchises augment M&A. our organic Our long-term ability backdrop, in and of that confident pipeline deploy M&A drive to capital current I’m our With our as is actively accretive examine we

continue to while continuing we’re sustainable growth in transformation become cost time our high also focused company to over be management. for single-digit our on We value a delivering vigilant Overall, shareholders.

I’ll turn Now, the over to Steve. call

Steve Voskuil

Avanos and IT pleased on Joe, goals. and sales good earnings XX%. we cost schedule to everyone. transformation implementation Thanks, XXX to I’m solid deliver increase million, morning, deliver remain an Overall, continued of our on delivered of and

Ready acquisition Game of Our the growth. contributed X%

double-digit our was overall Digestive as In X%, selling sales demand mix we in accelerated growth Excluding site another robust offset advertising by continue growth Game make inroads driven to solid our delivered in market. Digestive Health. Pain unfavorable Pain Interventional franchise lower product partially of by in America. X%. alternative continued North Growth in Investment direct-to-patient Health, quarter volumes prices COOLIEF and and increased the growth Ready, of Interventional in in

We the couple recently expect slowdown portfolio also help fourth Tube, Care temporary Despite to which to quarter our to round XX to Chronic the GJ we in in Digestive offering. saw volume growth French in see the in out a added the we Health, franchise our of factors. a growth due in Mic-Key strength

distributor First, seeing the we timing of from orders. are pressure

care capacity due lost to some business Second, oral internal constraints. we

Chronic the Our loss do factors this in potential of to profit Care business in came million quarter XX% XX% increased compared and XXXX. operating business. not year. year XX drive at the to positioned and been Medical Device last our ago, compared for XX a operating These new was million of we supply offset has view the margin and change now growth to are

quarters, several growth. continue over discussed to and we last for the increase short- investment we As long-term

the enhanced code, our the level spending to the for operating XXXX of a direct-to-patient million, quarter, R&D million a $XX year coupled the profit S&IP impacted as and divestiture ago. compared results dissynergies funding clinical $XX included for During support Adjusted ago, million totaled operations. to $XX from year from advertising. net million expected. accelerated The income quarter year down last we X in was $XX Adjusted investing from with as Cap CPT discontinued EBITDA the forecasted elevated evidence higher

As $X.XX contributed adjusted strong our performance. our Three per Joe which to was diluted this above of mentioned, earnings quarter, we earned expectations. share factors

XX% favorable improved manufacturing savings First, plants. cost efficiency our and of was by adjusted positively impacted margin in gross

to to return expect expect we margin XXs low our gross performance to to and ahead, Looking return as plants. to the historical in we adjusted inventory manufacturing take manage downtime

change were in spending Second, our expenses on despite the assumptions. the our short-term accelerated investment to lower support COOLIEF, focus forecast due our reflecting incentives, and lower operating to controllable

to sheet the quarter. largely tax or to expenditures We of of payment financial divestiture. the look Pain business and the of investing to year, projects we we expense benefit the similar adjusted stock marketing product Shifting lower-than-expected the balance end benefited finally, as launches the the support As expect to planned And effective rate we’ll in the of X continue the R&D to exercise Interventional and options recognized our accelerate results in prior our XX.X% tax from quarter. employee inflow free of the compared The flow, the and $XXX quarter million Cash for strong capital attributable $X decline on a million cash million $XX cash to quarter to S&IP flow a an an position on cash less cash the gain generation. tax from with operating is was the free in in from outflow activities ended year hand. ago. of

to significant firepower guidance. to and in strong our growth remains sheet Shifting balance have invest Our opportunities. we future

key We discontinued Acute business, in net quarter including now consolidation earnings our $X.XX, constant-currency of year includes in plan. share on full to earnings guidance earn expect we to remain opportunities our our on which Ready, and of we Device to that X% enhance compared and in both summary, maintaining the shareholder between basis, previous delivered continuing are with questions. diluted Chronic positions Game sales transformation adjusted increase from and have share Medical Care, operations. With and investing Based ready operator, headwinds per planning distributors and ahead to our are earnings fourth track updating $X.XX diluted on are trends assumption. take current We expect We that our In our profile adjusted net and us Pain expectation third-party to of continue IV and a X%. to Infusion sales we regulatory strong per a a financial between X% that, excluding value. X% growth post-divestiture anticipated softness and

Operator

first We’ll Instructions] our question-and-answer now And Larry James. the of session. Keusch comes from Raymond begin question [Operator

Larry Keusch

out? Joe, wondering what is about And talk Leiters. And just understand kind So drug things new the Care you bit in to to of how I bit this to versus people little the see little pain a resolution headwinds guess of looking to to driven of But of guess, if situation, these that understand being how can is, Acute shortages then by guess would me. again I’m how your you I of kind trying ability And much over the supply transition the forward, trying really segment. parse distribution I’m you a I do really progressing?

Joe Woody

I’ll X% in above Chronic X% roughly a and QX, about Larry, and Care of just X% had to We mid-single-digit, Acute consensus. say mystic and double-digit. is particular. Pain, were quarter for things had you IVP I’ll But in overall, to X% talk just very, which couple very about then performance with the to volume good

would Pfizer In into impact is when regulatory. stories market. the been drug, they on from back terms from of it’s told PharMEDium and Pain, the Acute And primarily different we’ve come

quarter. point had the also impact a was that X X.X down another go -- We in filler or

We percentage do back Pfizer they’ll X Pain. indications point come Acute PharMEDium overall, and gradually. back, impact So but have coming in are that

you drug for the of uses other be drug, that example, we as for If will is which the use. there an example, XX% take ropivacaine

in quarter XXXX. us half sort for us. see we do the So we with of ‘XX ‘XX a do the of bit of second second it being But into the see better or

Steve Voskuil

IV talk distributor on the in is IV typically Maybe, late buys lower would they Larry, consolidate lot ownership that the do intrigued attain talked about and that haven’t a past, of where we they’re year-end, a the a I inventories. rebate, X one side margin buy distributor working to rebate. sometimes large on But the to about new quarter pick on large the in in X, the large by the to quarter summer, with just consolidating as not couple a up business calls. think side we past distributors that And the in on the

impact bumpy in we so actually XXXX. less see then expect to profile normalize, little onetime kind order pattern that normalize, in And And a of bit QX.

Joe Woody

thesis confident And is mid-single-digit in We side. Acute the feel But the the IV going maintains feel still onetime to frustrating organic QX. our capital impact at very it’s have generally, like deploy. business, a that on in Pain we overall, forward But supply is achievable. growth the

very million for We’re takeout and M&A so or still really a cost program. $XXX strong

is So it’s with a supply, aware I drug of. the which everyone frustrating think element

Larry Keusch

Since just try Okay. you announced to the I as M&A, desire to in that then past And had a certainly Joe, think said you’ve get XXXX. your follow-up it deals X question. in mentioned was

So on heard guys process are of kind just again think your But the and that is stuff. temperature kind trying going, again, comments the we your to at temperature? I you November and to want like sounds pipeline that take here beginning on full take certainly of of how the you it’s are working just

Joe Woody

possible. is It

as Year, end the be New shortly the that we dialogue to to We’re of our turn conduct in for able very or After for corner. it our by and or another should very in fact active us year encouraged see number hard that very, love would just midterm, the we We But by to whether near efforts not it’s the predict. a of happens the pipeline really acquisition am the and to I in sure. areas.

Operator

Mishan Matt from KeyBanc. go comes Please of question next Our ahead.

Matt Mishan

of -- this the year. helped to being how us you you long-term order any based of up tell any can this magnitude? shortage Are not increase supply? many as accounts way by lose to impacted it on supply penetration result from Just has are sales in And a and going able then way this

Joe Woody

may roughly things, million generally, it. add in want being of couple $XX to But revenue about a say talked Steve we’ve impacted. I’ll Matt. to

If by fillers, has working you back, out our and X about point team step our headwind this nice actually our of finding a a with about and it’s job mitigating think done which pharmacies. of really accounts really different it X%

of extremely surgeons, strategy conversions year. that, our of encouraged at the to real in orthopedic by beginning progress was incisional Secondary our we’re which and the

other their availability, I And process in the back, sites. X be leaving of from story. that of looking particular and to new the comes using example, around those they’re have be source, terms using it’s days a that’s impactful. I we at for various And of it But as contracting, not drug used back time when moment XX% In health about and to at customers a be slower the sources said as if vendors. about a getting a our quality speed, And customers we because will look allocated the really up, on they’re then moment, that reasons, process think coming pain would at seen of a Leiters new it’s pumps. it, patients different relief the economic contracting, in in for there’ll as walking up is total ropivacaine ropivacaine knee ago, product the auditing better

Steve Voskuil

I part flosses as granular issues so trading impacted and that as the a add, we track really Obviously, have pre-fill big drug time, we’re get of would expect Joe more said, as other seen I continued all back level, get restored at with linger. supply shortage fairly and the do alternatives. We can Yes, anxious you’d over accounts have gas story to those hasn’t so been Pacira that a we to and far. on pedal. mean share

Matt Mishan

pieces And $XX in you did was Were moving there to expecting million like the then then inflow are as flow. that from you accounting on there? a had make you What from, that any I get on other one tax well? free quick the And the gain? divesture think cash payment cash

Steve Voskuil

And the payment at was we about estimated was transaction. what with that tax line time the million. the in Yes, of had $XX

no side. surprise was really on it that So

the inventory of got But quarter another bit. we two kind some effort, as that drivers inventory of quarter in brought some Those of want that a really rebranding quarter, other cash the clearly, past part are back rebranding. that, as The three. quarter probably get as our we we working of through still for third the build to drawn down we get biggest for

But Of earnings clouds really the are sale big the those in talked the of from for cash QX. the the noise call quarter course, drivers that untangling about we flow kind of up picture. two some second free

Dave Crawford

respect thing got some And say, is with Matt, cash, in. Dave. additional to this One I’d that we of

happen The Minor. that’s scheduled to we And is when Owens inventory XXXX. the in to back & piece going sell of other first to happen half

Matt Mishan

last question. And then Okay.

at talking -- unsustainable. as that it what the You walk look guys through you quarter this at strength were margin again? you you and Can gross is look and out the like the really But of that stands drivers down seems there.

Steve Voskuil

Yes, bit over up time to, savings now, QX, low-XXs get right in Obviously, kick we to still this last we’re quarter. quarters. a We a right the at have about third us But bit cost little and is little the restructuring landing very still couple quarter But We performances, strong at happy ‘XX, saw strong a have those did and transition a and broader for. build bit the plan is again, be contribute to to ahead low-XXs quarter is going where cost We’ll as plant sure the expect our in. a looking we’ll probably space of savings result. little right some stronger spot. of Matt. little probably ongoing I more mean where it’s a thinking

Operator

Capital next question comes Markets. Please Our from go Berenberg Misra Ravi of ahead.

Ravi Misra

secondly the kind what And then once is couple issues just your stabilize now? thoughts service market there? just of all growth does accounts? Can I against what’s once you growth on there. ability you kind pump kind outlook the that right then talk after you of you you So there? go do that guys limiting for think this resolved? we your peg And of wins existing Can how customers, the about done? your do as this supply of focus bit a mean, at these talk overall about about annualizing And ability where the are ON-Q existing -- strategy shortage, or you dynamics new new is little the to think versus with to on here how that’s

Joe Woody

that pump sells anybody affected manufactures, this. pumps Ravi, all all are they being equally by

still that or believe because eagerness move we is has It’s that the more are able mid-single-digit and pre-filler conversions we we customers the own about ahead high dealing are And less growth the there. our have over And drug. incisional And or they’re either converting third the impacted. single-digit. the we converting. as potential to into a fact their are they converting plans ones with found a say is of we’re surgeons this of get that time both orthopedic why are we another procedure that However, our that surgeons. pharmacy well as a of customers to are of still And

we’ve So with get that areas acquisition as improve as us progress more sort pick ability obviously seen we more like we potential maintaining forward of as and grower and overarching our in and back supply gradually which for we position of back, is why we and thesis make to comes up are again, mid-single-digit we our international.

Steve Voskuil

Yes, I new sales you business when that hit supply they’re to imagine then would frustrated able gets can converting being just you a issue, not say the supply. as and force

are more business. we of so on some think force so past to And this get could be that more again new unleash aggressive, sales them I of kind anxious the all

us, very optimistic wish we’re and We said, we about pump long-term in business. this for is remain growth some As the gaining us particular. Joe this once more. business gaining behind we’re the for new And

Ravi Misra

about to may what’s geographic broadly about And those you mean about the can be general highlight on this conversions. the to I OUS? in the the in encouraging just That’s there going there? are Can bit contribution quarter? mix grow coming speaking little hear OUS, you talk maybe customer U.S.,

Joe Woody

primarily the is broadly the U.S., in that’s Acute Ravi, focused. where Pain business

potential will And We’re smaller there? there’ll introduce time. of take question both me there. of And that into parts the remind starting and Europe Asia. again, be to level your of second part And a of some

Ravi Misra

was I to in OUS curious about just growth contribution just quarter? overall the

Joe Woody

of is contribution. Yes, part greater the the

Steve Voskuil

Yes.

Joe Woody

about is in asked have we place. And that Arjun Sarkar internationally, you

XXXX. be or into an summit. And is business year, just on And We’re he off And progressing there’ll their improvement on new strategic internal year-over-year. forming came on thereabouts plan. of team. a there’ll be in his This strategy that

around quarter-to-quarter. that. a markets probably trajectory. to with It makes talked little we pleased And change we’re focused to JPMorgan go our direct everyone before, that in Today, want we’ve distributors. or as little it of about about, revenue through that more we’ll XX% and So on is talk a lumpy in

of And more that performance really growth. have underlying business. generates leveled we one So a in that

Ravi Misra

then And the think those versus like adjust you I model, if anticipate reading right. about just one of with least those that or I’m publications that to submitted one, you last this growth where the last mean that business? planning are COOLIEF. way looks to at maybe Is to about we be on in it accelerated mentioned, Is quarter. our And are then about It going thinking kind journals, year? -- correct? conferences next should those right

Joe Woody

the did growth the growth direct-to-patient clinical in think the that’s uptick slight in I of be of It’s So the going studies generators. a and general available the yes, have the And capital to upon we based sale bulk quarter are just COOLIEF. good in of QX. -- And for the advertising. a

our to also that will But payers. the to conferences. we’re And importantly, discussions. bringing a Medicare constant in private be dialogue with with those kind more working We commercial of And we’ll as those bolsters recent well. be bringing legislation forward the

progressing we point said, we we have inflection XXXX where as So could reimbursement. think really an are to we in

Operator

next from our Stanley. Jonathan Demchick of question comes Morgan And Instructions] [Operator

Jonathan Demchick

Care on But rates. may This I you have be much delta. of, $XX what Wanted kind the shortage? of kind view could call points And really that’s into of as million the been it you from a mid-single quarter guess the kind was off we of one of you much Chronic kind first dropped from last you In was the Obviously issues have how disruption? guess, Obviously, has in dynamics. Maybe the implies I guidance how talked But declines. about next Acute to, a how total quantify much about implied on then mid-single-digit the hoping of follow-up. guidance I it, lower. quarter’s just I presale growing to have quarter. of that then talked digit little And fourth that start this lot from quick the Pain. drug a

Steve Voskuil

majority Yes, But maybe laid I’ll start Joe decline lift so between that what add digit distributor fourth with of for implied quarter. as -- on can QX. the the are quarter X a back we the on And drivers, pressures out business prepared commentary. to the and the We drug the pieces fourth that Care down. yes, We kind does We digits of about your together same under mid-single that works ours. some the on The of mid-single one, vast have mid-single math get by that’s guidance, really it of and Those impact reversion slow them supply. you do remarks. in distributor the normally in talked Chronic ON-Q the change. kind saw IV. for because constraints

Acute business. Pain want the But is add going anything in be you the QX. Joe, in we a bit we seeing fourth that? in the negative little little the majority on for a quarter for change to going the saw quarter. talked little that bit recall to distributor a You quarter, And be those to bit we’re Care. X of Chronic level second out fourth might that benefit think to We the about drivers of impact a in

Joe Woody

stocking and No, be a Care of of And outside a move to listened But that’s I distributors which place, Because was pretty pretty oral a only be as of all the thing about management, again, business so in up piece. X%. there’s in And distributor QX, double-digit that say calls I distributors continue a think the I’ve capacity of good. team in we QX, shifted have going IVP’s the in is the high was on of bit frankly year-to-date care, and more inventory on it Chronic which the through seems to much continued, would couple single-digit. we is timing QX other now with heavy an to inventory there interesting. in. It’s general. And

Steve -- QX have last year. we only X% also because really was it is that an comparator, have a So -- didn’t the mention tough frankly, a thing in growth

Jonathan Demchick

And were a Obviously, margin manufacturing then a on quick and they this the bit from quarter gross up just benefits. follow stronger the margins.

kind the into, ON-Q, said, to guess, And with how be be margin type stacking into synergies about, I headwind thinking margin then of that into but it from XQ You headwinds moving also quantify I the could should and of next guess, profile? thinking overall year, we kind possible maybe is the of forward?

Steve Voskuil

the if give Yes. take I of and kind know piece, I’ll don’t specifics question of I’ll the second -- I’ll you more on ON-Q. the

profitable a business. fact, ON-Q is obviously, In

But to do margin and have provided. year on we that the gross we’re fourth So the call. gross color right. to overcome. we’ve quarter with earnings well We’ll exactly for as as you’re that in Obviously, side more margin on have QX -- we able guidance that for has the an that full the effect get XXXX get the

XXXX we’ve the restructuring and we’ll through. layered We’ll on those margin of savouring’s rolling well. get savings have see in to those of as year, savings the to expect some plan. see We in layering longer-term, XXXX as have got much it, annualized more plan. begin some dissynergies restructuring didn’t We in. the cost This into cost XXXX call of top. We to roll gross do have But that through

the again the we pieces past. the on guidance give are ones big have as to we And at come moving talked that so next the year. But more year about in beginning next of

Operator

Kristen from ahead. comes Our question next go Barclays. Stewart of Please

Kristen Stewart

seems I just maybe know, right at going the kind I that earnings and sounds you half appreciate be or outside like to I around there the just on are control quarter now XXXX. numbers, to of look looking headwinds maybe your now performance, at for through. But that don’t to that $X.XX. And wanted third of XXXX. want to just if second lot give guidance it admittedly impact a you’re the are performance of walk I rather roughly that, are going

So year. Street’s close the that doesn’t necessarily to annualized out at so for where next

are headwinds outlook takes control would a some could should perhaps the particular Any and that be XXXX that? some ability you of to color in of that we on what of your that inability more to the or appreciated. help outside puts do be comfortable your So us terms to get considering these of bit little offer for are offset

Joe Woody

and back, happy welcome Kristen, So, answer to I’ll start. those questions.

little of pick then up Pain. come Acute the doing what think we on back headwinds, a I’ll are that bit will I Steve about some

we’re for a mid-single-digit season. Acute not because have going see give grower. business the to And year-to-date. just level, full It’s a Care, to forward. But X% spend reimbursement, February continued mid-single-digit be absolutely double-digit, the essentially, a in expect obviously, in It of more QX So moment, at that year. a this, Chronic guidance at going talked stay to then will high flu mid-single-digit about improving. and say in we that’s area though It’s as and of high just IVP really a we in grower. momentum the I to going single-digit. Pain, we It’s tough does a comp a that

fillers, are we’re our together the other with -- supply point-of-contacts at more innovative to Leiters like We chain. approaches looking

all, Just reminding And We don’t really pumps. the pre-fill. manufacture we drug don’t don’t we we drug. and the sell at sell everybody,

pumps. targets. are these the are And moving so we issues regulatory sell And that

approaches a growth new on Steve I’ll your manufacturing say have international that, As question, to and and down. the of back. the And maybe fill We why with FDA have risk. letters, we which But to a warning shut is gradual of The come because -- essentially, the is looking come last we Steve? up I intact. some that’s aware when coming a mid thing other drug broaden longer everyone we’re very is and term. innovative probably couple us, the think reduce and our our going the confident. we on to that chain We And pre-fill for thesis in the already year-over-year. both improvement opportunity supply supply in your it I leader so of we’re kind will in think They way. feel severe, elements more good But let And other would side. different are back was I’ll pick help it’s is think back. customers place. It’s do put a

Steve Voskuil

margins gross the business. business But with next Yes, our margin guidance fully online with on we’ve will drop as giving fundamental manufacturing a we addition, get impeded and also And think then the portfolio course, of just next Acute area. little Pain throughout right will bit And comes inside see gross products, year. portion benefit on that’s the mix the back of some Pain. time the the through. of but a earnings course stage, next of rest portion as accretion that where about of XXXX, a more that’s dynamic in cost-saving program margin of of natural past, year, you’ll over of the the be And in in the the Acute I not the now side, we’re over talked in that

are progression get continue benefits margin those expect initiatives that implemented And XXXX. do see roll transformation support to plank some a that to we fully so see time But in of this strategy. That’s They don’t track. over all will XXXX. the in through our to we business. all key begin on And in of

Kristen Stewart

as still the about of objectives back it next in cost June, good intact the guess longer-term So years you phasing savings was? still over feel couple you and the of outlined are the I

Steve Voskuil

when color the we thesis same. Yes, do. get we more We the absolutely, fundamental XXXX on closer. is But will have

of about that margin to over ability the margin talked growth high gross uplift opportunities accretive you third, back mid-single-digit portfolio, and particularly where structure. organic the then growth natural again, business to cost a are levels. the P&L capital live the deployment, single-digit Joe ultimately external think growth at as savings we margin about time on on that with take a If we’ve And to the that the through can earlier, leverage mentioned -- drive the

challenges Pain in intact. right the now fundamental that And thesis Acute so we that notwithstanding remains have

Operator

like concludes over conference for CEO, session. remarks. This closing our question-and-answer to Woody, to Joe turn any the I back would

Joe Woody

their in thank I’d everybody for interest Avanos. like to

we confident business fundamentals I’m solid. outlook, for The set can goals and in to tell, have the achieve our the business ability that are the As you ourselves. very of

shareholders. in want can Thank everyone presenting value next website presentation Investor our Stifel Healthcare deliver of found the you, continue We’re be at remind And I how everybody. be do And avanos.com. in for will the Conference well-positioned about our that section access to to information to I Tuesday New that York. Relations to

Operator

you now today’s has conference presentation. concluded. The for attending Thank

disconnect. now may You

Avanos Medical (AVNS) 6 Nov 182018 Q3 Earnings call transcript